[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [Benef](https://github.com/mm80843/T3.5/tree/main/docs/Benef/index.md) >> Individual ID:PBN__Benef_995 

# __Pathogen inactivation__

## Name of the Benefit

UVGI technology can effectively inactivate airborne pathogens, including viruses and bacteria, reducing the risk of infection transmission.

## Description of actual returns pertaining to this benefit

* [Private investors can benefit from increased demand and desirability of buildings with uv-based technologies, leading to higher asset value and potential premium rental rates.](https://github.com/mm80843/T3.5/blob/main/docs/BenefReturn/PBN__BenefReturn_1105.md)
* [Implementation of uvgi systems can lead to a reduction in the risk of airborne infections, resulting in healthier occupants and improved productivity.](https://github.com/mm80843/T3.5/blob/main/docs/BenefReturn/PBN__BenefReturn_1300.md)

## Articles mentionning this Benefit

* [Methods for air cleaning and protection of building occupants from airborne pathogens](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_240.md)
* [Indoor Air Quality: Rethinking rules of building design strategies in post-pandemic architecture](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_206.md)

## Stakeholders benefitting from this Benefit

* [Occupants](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_92.md)

## Risks which can benefit from this action

* [Uv-based technologies](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_994.md)
* [Uvgi](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_315.md)

